Johnson & Johnson
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $24,062,000 | $24,564,000 | $23,993,000 | $23,743,000 |
Gross Profit | 17,203,000 | 16,596,000 | 16,690,000 | 16,115,000 |
EBITDA | 6,395,000 | 7,191,000 | 9,288,000 | 8,742,000 |
EBIT | 5,180,000 | 7,511,000 | 6,799,000 | |
Net Income | 5,235,000 | 5,116,000 | 5,152,000 | 5,537,000 |
Net Change In Cash | 24,062,000 | 24,564,000 | 23,993,000 | 23,743,000 |
Free Cash Flow | 1,465,000 | 5,472,000 | 8,381,000 | 2,480,000 |
Cash | 21,688,000 | 19,709,000 | 18,231,000 | 18,577,000 |
Basic Shares | 2,445,200 | 2,439,000 | 2,428,600 | 2,419,100 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $94,193,000 | $88,821,000 | $85,159,000 | $79,990,000 |
Gross Profit | 68,558,000 | 61,350,000 | 58,413,000 | 55,394,000 |
EBITDA | 41,055,000 | 24,781,000 | 29,339,000 | 26,605,000 |
EBIT | 33,552,000 | 17,442,000 | 21,853,000 | 19,635,000 |
Net Income | 26,804,000 | 14,066,000 | 35,153,000 | 17,941,000 |
Net Change In Cash | 94,193,000 | 88,821,000 | 85,159,000 | 79,990,000 |
Cost of Revenue | -48,000 | |||
Free Cash Flow | 19,698,000 | 19,842,000 | 18,248,000 | 17,185,000 |
Cash | 19,709,000 | 24,105,000 | 21,859,000 | 12,889,000 |
Basic Shares | 2,429,400 | 2,429,400 | 2,560,400 | 2,663,900 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $2.70 |
2025-12-31 | $2.46 |
2025-09-30 | $2.80 |
2025-06-30 | $2.77 |